News & Events – Page 2 – www.brainwork.md

17th September 2020

Is disease-modifying treatment in primary progressive multiple sclerosis effective after all?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Is-disease-modifying-treatment-primary-progressive-multiplesclerosis-effective-after-all-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

Until now, several randomised controlled trials and real-world studies could not show the clinical benefit of disease‑modifying treatments (DMTs) in primary progressive multiple sclerosis (PPMS).1-4…

Anna Stelling, PhD
0
0

17th September 2020

Neurofilament light chain levels as a biomarker in multiple sclerosis

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Neurofilament-light-chain-levels-as-a-biomarker-in-multiple-sclerosis-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

It has been previously shown that the neuronal cytoskeletal protein neurofilament light chain (NfL) is released into the blood and cerebrospinal fluid (CSF) upon neuroaxonal…

Anna Stelling, PhD
0
0

17th September 2020

Do hormonal changes influence MS in women?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-Do-hormonal-changes-influence-MS-in-women.jpg 2400 1600 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 17th September 2020 23rd September 2020

There is a paradox in multiple sclerosis (MS): females appear to be more susceptible to the disease than males, but also have a better long-term…

Anne Carter, MA (Cantab)
0
0

31st August 2020

A reliable blood test for Alzheimer’s disease – is it becoming a reality?

https://www.brainwork.md/content/uploads/2020/08/Brainwork-Alzheimers-Dementia-Biomarkers-1024x683.jpg 1024 683 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 31st August 2020 31st August 2020

The increasing number of patients suffering from dementia caused by Alzheimer’s disease (AD) is a significant challenge for society and requires action by healthcare professionals…

Anna Stelling, PhD
0
0

25th August 2020

Speaking to Prof. Günther Deuschl – “The world is not a world of competitors, it is a world of collaborators.“

https://www.brainwork.md/content/uploads/2020/08/Deuschl-20201-.jpg 1041 1092 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 25th August 2020 25th August 2020

Even now, after having retired, Prof. Günther Deuschl’s ultimate goal is to cure patients. As an expert in movement disorders, he has contributed to this…

Anna Stelling, PhD
0
0

18th August 2020

New evidence against fluoxetine in stroke recovery

https://www.brainwork.md/content/uploads/2020/08/Brainwork-Fluoxetine-Stroke-Recovery.jpg 5805 3875 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 18th August 2020 18th August 2020

Stroke is a very common disease that leads to disability in around half of its survivors.1 It has been believed that fluoxetine, a selective serotonin-reuptake…

Anna Stelling, PhD
0
0

30th July 2020

Across specialties – a study on brain complications in COVID-19 patients

https://www.brainwork.md/content/uploads/2020/07/Brainwork-covid-head.jpg 5508 3672 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 30th July 2020 17th July 2020

Since December 2019, when clinicians first reported infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19), researchers have been trying to decipher the…

Anna Stelling, PhD
0
0

21st July 2020

Journal watch: Trial sheds light on optimal management of brain arteriovenous malformation

https://www.brainwork.md/content/uploads/2020/07/Brainwork-Journal-watch-1.jpg 6036 4024 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 21st July 2020 21st July 2020

The Background There has been longstanding uncertainty of whether medical management alone or additional interventional therapy is better for patients with a brain arteriovenous malformation…

Anna Stelling, PhD
0
0

17th July 2020

Head impacts associated with depression and decreased cognitive function

https://www.brainwork.md/content/uploads/2020/07/Brainwork-headinjury.jpg 6000 4000 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th July 2020 17th July 2020

Current research suggests that repetitive head impacts (RHI) resulting from contact sports, military service, domestic violence, or other sources are associated with cognitive and neuropsychiatric…

Anna Stelling, PhD
0
0

14th July 2020

CONy 2020

https://www.brainwork.md/content/uploads/2020/07/Brainwork-Cony-2020.jpg 4896 3264 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 14th July 2020 6th August 2020

The world Congress on Controversies in Neurology (CONy) this year will take place from the 2nd until the 5th of October 2020 on a virtual…

Anna Stelling, PhD
0
0

ECTRIMS 2020

This year’s congress organized by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) will be combined with the congress of Americas Committee…

https://www.brainwork.md/tag/ectrims-2020/

https://www.brainwork.md/content/uploads/2020/07/brainwork-ECTRIMS-2020.jpg 2000 2667 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 9th July 2020 17th September 2020

29th June 2020

Researchers found how ketamine works in depression – but that’s not all

https://www.brainwork.md/content/uploads/2020/06/brainwork_Ketamine_in_depression.jpg 6016 4016 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 29th June 2020 22nd June 2020

Depression is a widely-spread disease, with over 264 million people being affected worldwide.1 For a subset of patients suffering from major depressive disorder (MDD), administering…

Anna Stelling, PhD
0
0